Vitamin C Inhibited Pulmonary Metastasis through Activating Nrf2/HO-1 Pathway

© 2024 Wiley‐VCH GmbH..

As an important nutritional component, vitamin C (Vc) shows good antitumor activity in a variety of cancer, but there are few studies in pulmonary metastasis. In order to verify its anticancer and antimetastatic effect, the study sets up H22 pulmonary metastasis mouse model. The results show that intraperitoneal injection of Vc inhibits pulmonary metastasis through up-regulating the expression of Nrf2, HO-1, cleaved caspases 3 and 9, and causing DNA damage and apoptosis which is similar to the pro-oxidant effect of Vc in p53 null cells (H1299 cells). Meanwhile, oral administration of Vc up-regulates the expression of p53, directly activates Nrf2/HO-1 pathway, increases expression of cleaved caspases 3 and 9, and ultimately inhibits pulmonary metastasis, which is the same as the antioxidant result of Vc in p53 wild-type cells. In addition, Vc inhibits the proliferation and migration of lung cancer cells in a concentration-dependent manner and has little cytotoxic effects on normal cells. Notably, the experiment further illustrates that besides intravenous Vc, oral Vc significantly inhibits the pulmonary metastasis in mice. All in all, these findings provide new clues for Vc-treated pulmonary metastasis in clinical research.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:68

Enthalten in:

Molecular nutrition & food research - 68(2024), 6 vom: 02. März, Seite e2300706

Sprache:

Englisch

Beteiligte Personen:

Man, Shuli [VerfasserIn]
Bi, Jingxian [VerfasserIn]
Liu, Furui [VerfasserIn]
Xie, Wenwen [VerfasserIn]
Ma, Long [VerfasserIn]

Links:

Volltext

Themen:

Ascorbic Acid
Caspases
DNA damage
EC 3.4.22.-
Journal Article
Lung cancer
NF-E2-Related Factor 2
Nrf2/HO‐1
PQ6CK8PD0R
Pulmonary metastasis
Tumor Suppressor Protein p53
Vitamin C
Vitamins

Anmerkungen:

Date Completed 04.04.2024

Date Revised 04.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/mnfr.202300706

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369093119